SynthesisFrontiers in pharmacology2023

Efficacy and safety of PD-1/PD-L1 inhibitors in the treatment of recurrent and refractory ovarian cancer: A systematic review and a meta-analysis.

Siyuan Zeng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.